Our study showed that EMPA has a beneficial protective effect in CIS-induced ovarian damage, through various mechanisms, increasing antioxidants by activation of SIRT1/NRF2 pathway and decreasing ER stress by activation of SIRT1/GRP78 pathway. The gene discussed is HSPA5; the disease is in situ carcinoma.